Torsten Haferlach
Torsten Haferlach publishes mostly in Hematology, Molecular Biology and Genetics, on topics such as Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment and Chronic Myeloid Leukemia Treatments.
- World rank
- #239,366 of 7,710,434 ranked researchers
- Rank in Germany
- #12,104 of 364,343
- Works
- 2,044
- Citations
- 63k
- Citations per work
- 31.0
What does Torsten Haferlach research?
Torsten Haferlach's work is mostly in Medicine (48%), Biochemistry, Genetics and Molecular Biology (19%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences98948.4%
- Medicine98948.4%
- Everything else59529.1%
- Life Sciences46022.5%
- 1Hematology30% of their works
- 2Molecular Biology14% of their works
- 3Genetics14% of their works
- 4Cancer Research4% of their works
- 5Public Health, Environmental and Occupational Health4% of their works
- 6Immunology4% of their works
Research topics
- Acute Myeloid Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
- Chronic Lymphocytic Leukemia Research
- Acute Lymphoblastic Leukemia research
- Cancer Genomics and Diagnostics
- Lymphoma Diagnosis and Treatment
- Retinoids in leukemia and cellular processes
Which keywords describe Torsten Haferlach's research?
The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, Rituximab, JAK2 Mutation, Myelofibrosis, BCR-ABL and Imatinib.
- Retinoic Acid
- Lymphoma
- Mutational Signatures
- Childhood Cancer
- Genomic Aberrations
- Imatinib
- Myelofibrosis
- Rituximab
- AML
- Prognostic Factors
- Acute Myeloid Leukemia
- JAK2 Mutation
- BCR-ABL
- Chronic Lymphocytic Leukemia
- Acute Lymphoblastic Leukemia
- Cancer Genomics
- Classification
- Acute Promyelocytic Leukemia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Prognostic Factors1,5423 topics
- AML1,0671 topic
- Acute Myeloid Leukemia1,0671 topic
- Rituximab4052 topics
- JAK2 Mutation3771 topic
- Myelofibrosis3771 topic
- BCR-ABL3221 topic
- Imatinib3221 topic
- Chronic Lymphocytic Leukemia2721 topic
- Genomic Aberrations2721 topic
- Acute Lymphoblastic Leukemia2031 topic
- Childhood Cancer2031 topic
- Cancer Genomics1901 topic
- Mutational Signatures1901 topic
- Classification1331 topic
- Lymphoma1331 topic
- Acute Promyelocytic Leukemia1131 topic
- Retinoic Acid1131 topic
Where does Torsten Haferlach work?
Torsten Haferlach's main affiliation in the publication record is Munich Leukemia Laboratory (Germany), Germany.
How many publications and citations does Torsten Haferlach have?
OpenAlex counts 2,044 works and 63,312 citations for Torsten Haferlach, an h-index of 120, ranking #239,366 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Torsten Haferlach
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Torsten Haferlach. Posts are plain text and can be reported.